Artigo de periodico

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)

• Authors:
  • Song, Alice Tung Wan
  • Rocha, Vanderson Geraldo
  • Mendrone Júnior, Alfredo
  • Rodrigues, Rodrigo do Tocantins Calado de Saloma
  • Santis, Gil Cunha De
  • Benites, Bruno D.
  • Lima, Carolina Costa
  • Vargas, Taiani
  • Marques, Leonardo da Silva
  • Fernandes, Juliana C.
  • Breda, Felipe C.
  • Wendel, Silvano
  • Fachini, Roberta
  • Rizzo, Luiz V.
  • Kutner, José Mauro
  • Silva, Vivian Helena Iida Avelino da
  • Machado, Rafael Rahal Guaragna
  • Durigon, Edison Luiz
  • Chevret, Sylvie
  • Kallas, Esper Georges
• USP affiliated authors: SONG, ALICE TUNG WAN - FM ; ROCHA, VANDERSON GERALDO - FM ; RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP ; SANTIS, GIL CUNHA DE - FMRP ; SILVA, VIVIAN HELENA IIDA AVELINO DA - FM ; DURIGON, EDISON LUIZ - ICB ; KALLAS, ESPER GEORGES - FM ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
• Unidades: FM; FMRP; ICB
• DOI: 10.1016/j.lana.2022.100216
• Subjects: MICROBIOLOGIA; COVID-19; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO; PLASMA; SANGUE
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2022
• Source:
  • Título: Lancet Regional Health. Americas
  • ISSN: 2667-193X
  • Volume/Número/Paginação/Ano: v. 10, art. 100216, p. 1-10, 2022

Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
• Este artigo possui versão em acesso aberto
• URL de acesso aberto
• Versão do Documento: Versão publicada (Published version)
• Status: Artigo publicado em periódico de acesso aberto (Gold Open Access)

---

Download do texto completo

Tipo	Nome	Link
	Treatment of severe COVID...	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 13 mar. 2026.

• APA

  Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216

• NLM

  Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.lana.2022.100216

• Vancouver

  Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.lana.2022.100216

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
• Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
• Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
• C4d e PCR do VHC em tecido no diagnóstico diferencial entre rejeição e recidiva de hepatite C em pacientes transplantados de fígado
• Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
• Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
• Predictors of mortality in patients with yellow fever: an observational cohort study
• Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
• COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
• A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections